Loss narrowed 45.3% but total assets fell to $0.5m unprecedented low

The reported loss narrowed: PBT improved 45.3% to -NZ$0.4m and NPAT improved 45.3% to -NZ$0.4m, both classified above the company's historical range. Equity fell 55.8% to NZ$0.4m, while cash rose 151.5% to NZ$0.4m, implying material non-operating funding inflows during the year. Operating cash outflow narrowed 39.3% to -NZ$0.4m and capex remained nominal at -NZ$0.0m. No dividend was declared.

Total assets of NZ$0.5m sit below the company's historical range, and equity of NZ$0.4m is now smaller than the FY25 loss itself, meaning a further year of similar burn would fully consume the remaining equity base. Funding capacity, not earnings progression, is the dominant economic issue for this result.

The reported loss improvement is real but small in dollar terms. PBT and NPAT both improved 45.3%, classified above the historical baseline, but the absolute reduction is only NZ$0.4m on a still-negative result against a zero revenue base. There is no operating leverage available to extend that trajectory, because there is no revenue to scale.

Cash rose despite continuing operating losses. Cash increased NZ$0.3m to NZ$0.4m even though operating cash flow was -NZ$0.4m, implying roughly NZ$0.5m of inflows from investing (+NZ$0.2m) and financing activities. The composition and repeatability of those inflows is central to any assessment of residual runway and is not explained in the supplied excerpts.

The half-year context shows HY25 NPAT of -NZ$0.4m, implying a second-half loss of just -NZ$0.1m — an apparent deceleration in burn into H2. Whether that reflects timing of expenses or a genuine step-down in the cost base is not addressed in the release. Without revenue or a stated commercialisation timetable for the antimicrobial licence agreement referenced in the interim report, the result does not support a view on when the company can self-fund. Investors are left to infer runway and licence-royalty triggers rather than test them against management guidance.

There is no tax distortion (effective rate 0.0% in both periods) and no working-capital cushion masking the result, so the headline improvement reflects cost reductions rather than accounting timing.

The quality story is overshadowed by the balance sheet, however. ROE of -75.6% is below the company's historical baseline despite the loss narrowing, because equity has fallen faster than the loss has improved. Total assets of NZ$0.5m versus the historical range of approximately NZ$0.9m–NZ$2.2m mean the company is operating at a previously unseen scale, and a further loss of similar magnitude would require external funding to sustain even this footprint. The result is therefore best read as care-and-maintenance burn at a smaller absolute level rather than measurable progress toward a self-sustaining operating model.

This briefing cannot assess going-concern conclusions because audited financial statements and any auditor commentary are not available in this preliminary, unaudited release.